Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Fruquintinib Combined With Sintilimab and SOX in Locally Advanced Gastric/GEJ Adenocarcinoma
NCT07658872Phase 2Not yet recruiting
- Sponsor
- Sichuan University
- Start
- Jun 2026
- Primary completion
- May 2027
01
Overview
A Phase 2 trial of fruquintinib in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Sichuan University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
fruquintinib
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07658872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658872.